Merck & Co., Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Merck & Co., Inc. (MRK) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $41.98 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $41.98B.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $45.93B.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $52.66B.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $51.91B.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $41.98B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $45.93B 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $52.66B 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $51.91B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $49.06B 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $48.40B 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $46.37B 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $44.56B 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $43.65B 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $40.42B 10-Q · filed 2025-08-05 | |
| 2023-12-31 | $37.63B 10-K · filed 2026-02-24 | |
| 2023-09-30 | $41.30B 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $38.74B 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $46.91B 10-Q · filed 2024-08-05 | |
| 2022-12-31 | $46.06B 10-K · filed 2026-02-24 | |
| 2022-09-30 | $44.52B 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $43.32B 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $40.95B 10-Q · filed 2023-08-07 | |
| 2021-12-31 | $38.26B 10-K · filed 2025-02-25 | |
| 2021-09-30 | $35.86B 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $33.39B 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $27.04B 10-Q · filed 2022-08-05 | |
| 2020-12-31 | $25.40B 10-K · filed 2024-02-26 | |
| 2020-09-30 | $29.27B 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $27.74B 10-Q · filed 2021-11-05 | |
| 2020-03-31 | $26.30B 10-Q · filed 2021-08-09 | |
| 2019-12-31 | $26.00B 10-K · filed 2023-02-24 | |
| 2019-09-30 | $26.93B 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $27.74B 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $27.67B 10-Q · filed 2020-08-05 | |
| 2018-12-31 | $26.88B 10-K · filed 2022-02-25 | |
| 2018-09-30 | $32.66B 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $32.77B 10-Q · filed 2019-11-05 | |
| 2018-03-31 | $33.90B 10-Q · filed 2019-08-06 | |
| 2017-12-31 | $34.57B 10-K · filed 2021-02-25 | |
| 2017-09-30 | $38.50B 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $39.71B 10-Q · filed 2018-11-06 | |
| 2017-03-31 | $40.09B 10-Q · filed 2018-05-08 | |
| 2016-12-31 | $40.31B 10-K · filed 2020-02-26 | |
| 2016-09-30 | $43.96B 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $43.45B 10-Q · filed 2017-08-08 | |
| 2016-03-31 | $43.90B 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $44.77B 10-K · filed 2019-02-27 | |
| 2015-09-30 | $45.68B 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $46.64B 10-Q · filed 2016-08-08 | |
| 2015-03-31 | $47.92B 10-Q · filed 2016-05-09 | |
| 2014-12-31 | $48.79B 10-K · filed 2018-02-27 | |
| 2014-09-30 | $45.36B 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $48.52B 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $52.56B 10-Q · filed 2015-05-07 | |
| 2013-12-31 | $52.33B 10-K · filed 2017-02-28 | |
| 2013-09-30 | $50.01B 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $50.10B 10-Q · filed 2014-08-07 | |
| 2013-03-31 | $55.61B 10-Q · filed 2014-05-08 | |
| 2012-12-31 | $55.46B 10-K · filed 2016-02-26 | |
| 2012-09-30 | $58.21B 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $57.67B 10-Q · filed 2013-08-07 | |
| 2012-03-31 | $57.31B 10-Q · filed 2013-05-09 | |
| 2011-12-31 | $56.94B 10-K · filed 2015-02-27 | |
| 2011-09-30 | $57.60B 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $57.92B 10-Q · filed 2012-08-07 | |
| 2011-03-31 | $56.84B 10-Q · filed 2012-05-08 | |
| 2010-12-31 | $56.80B 10-K · filed 2014-02-27 | |
| 2010-09-30 | $58.05B 10-Q · filed 2011-11-08 | $58.05B 10-Q · filed 2010-11-08 |
| 2010-06-30 | $57.66B 10-Q · filed 2011-08-08 | $57.67B 10-Q · filed 2010-08-06 |
| 2010-03-31 | $60.34B 10-Q · filed 2011-05-09 | $60.34B 10-Q · filed 2010-05-07 |
| 2009-12-31 | $61.48B 10-K · filed 2013-02-28 | $61.49B 10-K · filed 2010-03-01 |
| 2009-09-30 | $25.35B 10-Q · filed 2010-11-08 | |
| 2009-06-30 | $22.74B 10-Q · filed 2010-08-06 | |
| 2008-12-31 | $21.17B 10-K · filed 2012-02-28 | $21.17B 10-K · filed 2010-03-01 |
| 2007-12-31 | $20.59B 10-K · filed 2011-02-28 | $20.59B 10-K · filed 2010-03-01 |
| 2006-12-31 | $19.97B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |